SETD2 and miR-21 as therapeutic targets for NUT midline carcinoma
Nana Yoshida(Asahikawa Medical University), Yoshinobu Ohsaki(Asahikawa Medical University)
Cited by 0
Related Papers
Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
|International Journal of Oncology|2017|34